Afuresertib

Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively.

$ 1,175.60 1175.6000000000001 USD $ 1,175.60

1,175.60 €

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Internal Reference: cell25sk38674
Size: 100mg